CorMedix surges after better-than-expected Q2 results
CorMedix Inc. (NASDAQ: CRMD) surged 23.6% after the company reported better-than-expected second-quarter financial results.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.